Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Effect of Recombinant Human Granulocyte Colony- Stimulating Factor on Neutrophilic Expression of CD11b in Septic Neonates

NCT01479114 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT01479114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01479114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Effect of Recombinant Human Granulocyte Colony- Stimulating Factor on Neutrophilic Expression of CD11b in Septic Neonates
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2009
Completion date
May 31, 2010
Enrollment
90 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal sepsis